Additional chromosome aberrations in acute promyelocytic leukemia: Characteristics and prognostic influence

Medical Oncology

Volumn 17, Issue 4, 2000, Pages 307-313

  Pantic, M ^a   Novak, A ^a   Marisavljevic, D ^a   Djordjevic, V ^a   Elezovic, I ^a   Vidovic, A ^a   Colovic, M ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Additional chromosome abnormalities; APL; Prognosis

Indexed keywords

RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 22; CLINICAL ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; HUMAN CELL; HYPOFIBRINOGENEMIA; MALE; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT;

EID: 0033763906     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02782196     Document Type: Article

References (23)

1. All trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results
2. Differentiation therapy of acute promyelocytic leukemia
3. The molecular biology of acute promyelocytic leukemia
4. Complex variant 15;17 translocation in acute promyelocytic leukemia. A case report and review of three-way translocations
5. Cytogenetic studies in acute promyelocytic leukemia: A survey of secondary chromosomal abnormalities
6. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukemia: Cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the MRT ATRA Trial
7. Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukemia
8. Incidence and implication of additional chromosome aberration in acute promyelocytic leukemia with translocation t(15:17)(q22:q21): A report on 50 patients
9. Secondary cytogenetic changes in acute promyelocytic leukemia - Prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: A Cancer and Leukemia Group B study
10. Proposals for the classification of the acute leukemias
11. Effect of all-trans-retinoic acid alone or in combination with chemotherapy in newly diagnosed acute promyelocytic leukemia
12. Effect of all trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial
13. Rapid method for obtaining high quality chromosome banding in the study of hemopoietic neoplasia
14. Nonparametric estimation from incomplete observation
15. Design and analysis of randomized clinical trials requring prolonged observation of each patient. II. Analysis and examples
16. Regression models and life tables
17. Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia
18. High frequency of trisomy 8 in acute promyelocytic leukemia: A fluorescence in situ hybridization study
19. The significance of trisomy 8 in de novo acute myeloid leukemia: The accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group
20. Acute promyelocytic leukemia with additional chromosomal abnormalities and absence of Auer rods
21. Acute promyelocytic leukemia: Clinical relevance of two major PML-RARα isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse
22. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PML-RARα isoform and CD13 expression in patients treated with all-trans retinoic acid